A U.S. cannabis company has made an unsolicited bid to acquire Aurora Cannabis Inc., prompting the Edmonton-based firm to form a special committee to evaluate the offer. Curaleaf Holdings Inc. disclosed its intention to purchase all shares of Aurora, aiming to create a combined cannabis entity operating in 17 countries across Europe, North America, and other global markets.
Curaleaf, headquartered in Stamford, Conn., and listed on the Toronto Stock Exchange, decided to publicly announce its bid after unsuccessful private negotiations with Aurora’s leadership. Despite sending letters of intent on June 23 and July 7 outlining their proposal, Curaleaf claimed that Aurora’s board declined to engage in meaningful discussions.
In response, Curaleaf proposed to pay Aurora shareholders $4 US per share, along with an additional $0.75 US cash for each Aurora share. Aurora acknowledged receiving the letters but disputed Curaleaf’s assertion that it refused to consider the offer. The Canadian company stated that its lead independent director had communicated with Curaleaf’s CEO as recently as July 24, emphasizing their focus on executing the business plan.
Aurora plans to convene a special committee of independent directors to review the proposal’s alignment with stakeholders’ interests. While expressing uncertainty about finalizing a deal, Aurora emphasized its commitment to operations. Financial analysts cautioned that Curaleaf’s offer undervalues Aurora’s long-term potential, citing Aurora’s market leadership, product portfolio, and regulatory expertise as key value drivers.
Curaleaf believes that merging with Aurora would leverage their global distribution network and Aurora’s medical cannabis franchise, cultivation, and manufacturing capabilities. The combined companies have generated over $1.5 billion US in revenue in the past year, with Curaleaf anticipating annual cost synergies of $40 million US from the acquisition.
Curaleaf’s CEO, Boris Jordan, views the merger as mutually beneficial for both sets of shareholders, offering a diversified global platform and increased exposure to favorable U.S. regulatory trends.